Clinical Trial Update: Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial update of a three-drug regimen (irinotecan, oxaliplatin, and TS-1) for untreated metastatic colorectal cancer; current status is UNKNOWN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Colorecal Neoplasms, Secondary | Phase 2 | Status: UNKNOWN